I now have comprehensive source data. Let me compile the complete trimester-wise answer.
Complications of GDM - Trimester Wise
Note: GDM itself is typically diagnosed at 24-28 weeks (late 2nd trimester). However, many exam questions ask about complications of diabetes in pregnancy (including pre-gestational/unrecognized early diabetes), so the table below covers all trimesters across that spectrum. Complications relevant specifically to diagnosed GDM are emphasized.
1st Trimester (Weeks 1-13)
These complications apply primarily when pre-gestational diabetes is undetected or poorly controlled before/early in pregnancy. True GDM is rarely diagnosed this early.
| Complication | Notes |
|---|
| Spontaneous abortion | Chronic maternal hyperglycemia is a recognized cause of 1st trimester pregnancy loss |
| Congenital malformations | Strongly linked to poor glycemic control during organogenesis (weeks 3-8). Risk is at least doubled. Most common: cardiac defects (VSD, transposition), neural tube defects (sacral agenesis is pathognomonic), renal anomalies |
| Diabetic embryopathy | Caudal regression syndrome (sacral agenesis) - hallmark lesion |
| DKA risk | Diabetic ketoacidosis can occur at lower blood glucose thresholds in pregnant women than non-pregnant women |
Key point: Congenital malformation rate correlates directly with HbA1c during organogenesis. A preconception HbA1c <6% is targeted to minimize this risk (Harrison's, 2025).
2nd Trimester (Weeks 14-26)
GDM is formally diagnosed in this window (typically 24-28 weeks via OGTT). Complications begin to emerge as insulin resistance peaks.
| Complication | Notes |
|---|
| Gestational hypertension / Pre-eclampsia | GDM directly increases risk; one of the most serious maternal complications |
| Polyhydramnios | Excess amniotic fluid from fetal polyuria driven by fetal hyperglycemia |
| Early fetal macrosomia | Fetal hyperinsulinism from maternal hyperglycemia drives excessive fetal growth - first detected by ultrasound in 2nd trimester |
| Increased insulin requirements | Physiologic insulin resistance increases from ~0.7-0.8 units/kg (1st trimester) to 0.8-1 unit/kg (2nd trimester) |
| Preterm labor (risk begins) | Uterine overdistension from polyhydramnios; also associated with GDM directly |
| UTIs and infections | Glucosuria favors infection; indirect maternal risk |
3rd Trimester (Weeks 27-40) - Highest Risk Period
This is when the majority of GDM complications peak in severity.
Maternal Complications
| Complication | Notes |
|---|
| Pre-eclampsia / Gestational hypertension | Risk remains high; worsens toward term |
| Polyhydramnios | Peaks in 3rd trimester; increases uterine distension and preterm labor risk |
| Need for cesarean section | Increased rate due to macrosomia, malpresentation, failed induction |
| DKA | Can occur at relatively low blood glucose in pregnancy |
| Preterm labor | From polyhydramnios and uterine overdistension |
Fetal / Neonatal Complications
| Complication | Notes |
|---|
| Macrosomia (LGA - large for gestational age) | Primary impact of GDM; birth weight >4000 g. Drives most delivery complications |
| Stillbirth / Intrauterine fetal demise | Risk roughly proportional to degree of hyperglycemia; fetal surveillance started at 34-36 weeks |
| Shoulder dystocia | Newborns >4000 g responsible for 42-74% of shoulder dystocia cases |
| Birth trauma / Brachial plexus injury | Result of shoulder dystocia during delivery |
| Fetal growth restriction | Less common; occurs in GDM women with underlying vascular disease |
| Neonatal hypoglycemia | Due to fetal hyperinsulinism persisting after birth (cord cut removes maternal glucose) |
| Neonatal hyperbilirubinemia (jaundice) | From polycythemia and red cell breakdown |
| Neonatal polycythemia | Fetal hyperinsulinism stimulates erythropoiesis |
| Neonatal respiratory distress syndrome | Insulin delays fetal lung maturation (surfactant production) |
| Neonatal hypocalcemia | Metabolic complication; mechanism involves hypomagnesemia |
Postnatal / Long-Term Complications
Though not trimester-specific, these are important:
- Mother: GDM confers a 7-10 fold increase in risk of future Type 2 diabetes. Nearly 50% develop impaired glucose metabolism within 10 years. Increased cardiovascular risk (obesity, hypertension, dyslipidemia). Screen with 75g OGTT at 4-12 weeks postpartum.
- Offspring: Increased future risk of obesity and Type 2 diabetes from intrauterine hyperglycemic exposure.
Quick Summary Table
| Trimester | Key Maternal Complications | Key Fetal/Neonatal Complications |
|---|
| 1st | Spontaneous abortion, DKA | Congenital malformations (cardiac, NTD, caudal regression), embryopathy |
| 2nd | Pre-eclampsia, gestational HTN, UTI | Early macrosomia, polyhydramnios |
| 3rd | Pre-eclampsia, polyhydramnios, CS, preterm labor | Macrosomia, stillbirth, shoulder dystocia, birth trauma |
| Neonatal | - | Hypoglycemia, hyperbilirubinemia, polycythemia, RDS, hypocalcemia |
| Long-term | Type 2 DM, CVD risk | Obesity, Type 2 DM |
Sources: Goldman-Cecil Medicine, 2 Vol. Set | Creasy & Resnik's Maternal-Fetal Medicine | Harrison's Principles of Internal Medicine 22E (2025) | Robbins & Cotran Pathologic Basis of Disease | Fuster and Hurst's The Heart, 15th Ed.